Financial Data and Key Metrics Changes - The company reported a record second quarter adjusted operating profit of $298 million, up 20% from $248 million in 2024, with an adjusted operating profit margin of 7.9%, improved from 7.3% in 2024 [5][28] - Consolidated sales for the second quarter were $3.8 billion, representing an 11% increase or $374 million compared to the prior year [28] - Adjusted net income from continuing operations was a record $217 million compared to $192 million in 2024, with adjusted EPS at $0.55 per share compared to $0.51 per share in 2024 [28] Business Segment Data and Key Metrics Changes - The packaged meat segment delivered an adjusted operating profit of $296 million with a margin of 14.2%, despite higher raw material costs, and sales increased by 6.9% to $2.1 billion [29] - The fresh pork segment reported an adjusted operating profit of $30 million, up from $17 million in 2024, with a margin of 1.4% [30] - The hog production segment achieved an adjusted operating profit of $22 million, compared to a loss of $10 million in 2024, with sales increasing by 8.4% to $840 million [31][32] Market Data and Key Metrics Changes - The company noted a 4.5% increase in sales volume for packaged meats, driven by a favorable product mix and a later Easter holiday [29] - Fresh pork segment sales increased by 5% year over year, primarily due to a 3.3% increase in average selling price and a 1.7% increase in volume [31] - The hog production segment's sales increase was attributed to higher external grain and feed sales and the sale of commercial hog inventories [32] Company Strategy and Development Direction - The company has five strategic growth priorities: increasing profits in packaged meats, growing fresh pork profitability, achieving a best-in-class cost structure in hog production, optimizing operations, and evaluating synergistic M&A opportunities [11] - The focus remains on enhancing product mix, volume growth, and innovation in the packaged meat segment, which represents 55% of consolidated sales [12][14] - The company aims to maximize product value across channels in the fresh pork segment and optimize operations to deliver efficiencies [21][24] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in navigating a dynamic consumer spending and geopolitical environment, raising the full-year outlook for adjusted operating profit primarily due to improved hog production segment performance [10][11] - The company anticipates total sales growth in the low to mid-single-digit percent range compared to fiscal 2024, with adjusted operating profit expectations for packaged meats and fresh pork remaining stable [36][37] - Management highlighted the importance of delivering value and convenience to consumers, particularly in the packaged meats segment, amidst cautious consumer spending [12][13] Other Important Information - The company has a strong balance sheet with a net debt to adjusted EBITDA ratio of 0.7 times and liquidity of $3.2 billion [34] - Capital expenditures for the first half were $158 million, with over 50% allocated to projects driving growth [35] - The company paid quarterly dividends of $0.25 per share and expects to maintain a $1 per share annual dividend [35] Q&A Session Summary Question: Insights on consumer shifts within packaged meats and private label trends - Management noted that while there is an increase in private label share growth, their private label business provides a competitive advantage due to high-quality offerings [46][47] Question: Visibility on hog prices and their impact on profitability - Management indicated confidence in hog prices supported by market dynamics and improvements in hog production operations [49][50] Question: Confidence in packaged meats profitability amidst rising raw material costs - Management emphasized efficiency improvements and a strong product portfolio that allows them to mitigate raw material cost impacts [56][58] Question: Dynamics around hog production hedging and mark-to-market impacts - Management clarified that mark-to-market adjustments impacted second quarter results but overall business performance remains strong, leading to an increased full-year outlook [63] Question: Expectations for volume performance in packaged meats - Management expressed confidence in volume growth driven by product innovation and strong foodservice sales [72][73] Question: Competitive environment for packaged meats and promotional activity - Management highlighted a focus on quality over quantity in promotional strategies, leading to improved profit margins [80][81]

Financial Data and Key Metrics Changes - FGI reported total revenue of $31 million in Q2 2025, representing a year-over-year increase of 5.5% [6][13] - Gross profit was $8.7 million, a decrease of 2.9% compared to the prior year [6][13] - Gross margin declined to 28.1% from 30.5% in 2024, primarily due to the ongoing tariff environment [7][14] - Operating expenses increased by 1.3% to $9.5 million from $9.4 million in the prior year [14] - GAAP operating loss was $800,000, compared to a loss of $500,000 in the prior year [14] Business Line Data and Key Metrics Changes - Revenue from sanitary ware increased by 4.3% year-over-year [9] - Bath furniture revenue increased by 2.7% year-over-year due to market-aligned pricing and design [8] - Shower systems revenue declined by 11.2%, despite positive demand trends [9] - Other revenue, primarily from covered bridge cabinetry, increased by 67.7% driven by order momentum and expanded geographies [9] Market Data and Key Metrics Changes - Revenue in the U.S. declined by 0.4%, while revenue grew by 236.7% in Canada and Europe [8] - The company is focusing on a "China plus one" strategy to diversify sourcing [7][24] Company Strategy and Development Direction - FGI is investing in organic growth initiatives across brands, products, and channels, referred to as the BPC strategy [6] - The company is actively diversifying its global sourcing base, with significant changes expected in the sourcing footprint by next year [24] - Strategic investments are aimed at driving above-market organic growth in the future [9] Management's Comments on Operating Environment and Future Outlook - The management expressed confidence in navigating the tariff environment, citing strong relationships with suppliers and customers [11][34] - The order pipeline is recovering, although some customers remain cautious due to tariff uncertainties [12][22] - Management anticipates that new business programs will contribute positively to margins in the second half of the year [27][40] Other Important Information - FGI maintains its 2025 revenue guidance of $135 million to $145 million, with adjusted operating income guidance ranging from negative $2 million to positive $1.5 million [15] - Total liquidity at the end of Q2 was $16.4 million, deemed sufficient to fund growth initiatives [15] Q&A Session Summary Question: Concerns about demand degradation due to tariffs - Management indicated that the pause in orders was primarily due to uncertainty surrounding tariffs, which led customers to hesitate in purchasing inventory [20][21] Question: Impact of the "China plus one" strategy on all business segments - Management confirmed that the strategy will impact all business segments, including sanitary ware, and significant changes in the global sourcing footprint are expected [23][24] Question: Trends in operating expenses and gross margins for the second half - Management noted that they are closely monitoring expenses and expect gross margins to remain in the upper 20s, driven by new business programs [25][27] Question: Improvement in the order pipeline since the beginning of Q2 - Management reported a positive trajectory in the order pipeline, recovering momentum prior to the tariff impact [36][39] Question: Clarification on gross margins and guidance for the back half of the year - Management indicated that they expect to rebound in gross margins based on original plans, despite delays caused by tariffs [40]

Lifeway Foods (LWAY) Q2 2025 Earnings Call August 12, 2025 09:00 AM ET Speaker0Good morning. Welcome to LifeWay Foods' Second Quarter twenty twenty five Conference Call. On the call with me today is Julie Smolensky, President and Chief Executive Officer. By now, everyone should have access to the press release that went out this morning. If you have not received the release, it is available on the Investor Relations portion of LifeWay's website at www.lifewayfoods.com.A recording of this call will be availa ...

Financial Data and Key Metrics Changes - Revenue for the fiscal 2026 first quarter was $39.6 million, a slight decline from $40.9 million in the same quarter last year, primarily due to shipment delays [12] - Gross profit increased by 31.2% to $6.1 million from $4.6 million in the same quarter last year, with gross margin rising to 15.4% from 11.3% [12][13] - Operating income improved to $959,000 from an operating loss of $829,000 in the prior year quarter [13] - Net income for the fiscal 2026 first quarter was $324,000, recovering from a net loss of $1.4 million in the same quarter last year [14] - Cash and restricted cash totaled $7.5 million, with net working capital at $34.6 million [15] Business Line Data and Key Metrics Changes - The company successfully completed production of the first phase of a major order from a U.S.-based multinational retailer, indicating strong operational performance [5] - The expansion of manufacturing facilities in Amman was completed in June, with an estimated 15% increase in production capacity expected to contribute to performance starting in the second fiscal quarter [10][11] Market Data and Key Metrics Changes - The company is experiencing increased inquiries from global brands seeking to diversify their manufacturing away from Asia, particularly in light of the 15% U.S. tariff on products from Jordan [3][9] - Shipping logistics have improved significantly since mid-July 2025, allowing for more reliable shipping routes to support global customers [9] Company Strategy and Development Direction - The company is focused on diversifying its customer base and product mix to optimize production capacity and improve margins [10] - Future expansion plans are being evaluated, with a cautious approach due to geopolitical instability and tariff uncertainties [23][24] - The company aims to enhance operational efficiency while exploring larger-scale expansion plans for the coming year [16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about growing customer demand and the potential impacts of tariff changes and geopolitical instability [6] - The company is consulting with international tax experts to optimize its tax structure, which is currently affected by local taxes in Jordan and Hong Kong [14][36] Other Important Information - The company declared a quarterly regular dividend of $0.05 per share, payable on August 29, 2025 [17] - The company is booked through February 2026, with additional capacity expected to be gradually integrated [37] Q&A Session Summary Question: Are there now tariffs being paid for products from Jordan? - Yes, currently there is a 15% tariff [19] Question: Was there a sales shift from the first quarter into the second quarter? - Yes, a few orders were shifted to July, but it was not significant [21] Question: Can you provide details on longer-term expansion plans? - The company is planning a longer-term expansion but is cautious due to geopolitical uncertainties and tariffs, focusing on training new workers and expanding existing facilities for now [23][24] Question: Can you elaborate on the relationship with Hansel and order activity? - The company has secured two significant orders from Hansel, with ongoing discussions for further collaboration [28][29] Question: What is the effective tariff rate compared to other countries? - The current tariff for Jordan is 15%, which is competitive compared to other countries like Bangladesh and Vietnam [46][50] Question: How is the joint venture with Busana performing? - The joint venture has been terminated as the company can directly deal with customers [56]

Financial Data and Key Metrics Changes - Revenue for the second quarter of 2025 was approximately $2 million, down from $6 million in the same quarter last year, reflecting the impact of divestitures in 2024 [15] - Lease operating expense for the quarter was $1.6 million or $32.14 per BOE, compared to $3.1 million or $27.69 per BOE in the same quarter last year, indicating a decrease due to divestitures [16] - Cash, general, and administrative expenses were $1.7 million for 2025, aligning with quarterly run rate expectations [16] - As of June 30, 2025, the company had no debt outstanding on its $20 million revolving credit facility and a cash position of over $6.7 million [17] Business Line Data and Key Metrics Changes - The company drilled its second and third industrial gas wells targeting the helium and CO2 rich Dupro formation, achieving peak rates of approximately 12.2 million cubic feet per day with a gas composition of 85% CO2, 5% natural gas, and 0.4% helium [6][7] - The independent resource report confirmed net contingent resources of 444 billion cubic feet of CO2 and 1.3 billion cubic feet of helium, among the largest known deposits of its kind [7] Market Data and Key Metrics Changes - The company emphasized its unique competitive positioning in the helium market, as most US helium production is tied to heavy hydrocarbon gas streams, while its project is sourced from a limited hydrocarbon stream, resulting in a lower environmental footprint [8] Company Strategy and Development Direction - The primary focus is on the development of the Montana-based industrial gas project, which is expected to meet growing demand and deliver strong economics [5] - The company aims to build a full cycle platform that spans upstream production, midstream processing, and long-term carbon management while maintaining strict capital discipline [12] - The strategy includes investing in the core Montana industrial gas project, monetizing non-core legacy assets, and maintaining capital discipline to position 2026 as a breakout year [13] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, highlighting the Kievan Dome as a first mover opportunity in the industrial gas sector that cannot be replicated [11] - The company is set up for 2026 to be a stellar year as it advances its projects [54] Other Important Information - The company has initiated its EPA monitoring reporting and verification plan, targeting submission in September and approval by spring 2026, which may allow access to federal carbon credits under section 45Q [11] - Construction costs for the processing plant are expected to be under $10 million, funded by the existing balance sheet and modest strategic use of debt [9] Q&A Session Summary Question: Details on the resource report - Management was pleased with the resource report, confirming previously held beliefs about the large resource potential, with no surprises in the final numbers [24][25] Question: Goals for different offtake streams - Management aims to control offtakes for CO2 and helium, with expectations to enter into helium offtake agreements by the end of the year [31][32] Question: Helium concentration on drilled wells - Management acknowledged variations in helium concentration, stating that while current levels are slightly lower than expected, they remain economically viable [38][40] Question: Processing plant development changes - Management indicated that the development of the processing plant is being fine-tuned to optimize costs and economics, with no significant complications reported [46][47] Question: Future SG&A expenses - Management expects SG&A expenses to decrease in the near term as one-time costs associated with project development lessen [50]

NeurAxis (NRXS) Q2 2025 Earnings Call August 12, 2025 09:00 AM ET Speaker0Good day, everyone, and welcome to the Neuraxis Reports Second Quarter twenty twenty five Financial Results. At this time, all participants are in a listen only mode. After the presentation, there will be a question and answer session. To participate, you will need to press 11 on your telephone, and you will hear a message advising your hand is raised. To withdraw your question, simply press 11 again.If you would like to ask the quest ...

Financial Data and Key Metrics Changes - Total revenues for the first half of 2025 reached approximately €100 million, marking a significant year-over-year growth [4] - Cash position exceeded €160 million, indicating a strong cash influx and reduced operating cash burn [4][29] - Product sales increased to €91 million from €68.3 million in 2024, representing a growth of 33.3% [23] - Total revenues rose to €97.6 million from €70.8 million in 2024, an increase of 37.8% [25] - Adjusted EBITDA for 2025 was reported at minus €6.8 million, compared to a positive EBITDA of €66.2 million in the previous year [29] Business Line Data and Key Metrics Changes - IXIARO sales reached €54.7 million, increasing by 30.6% year-over-year [23] - DUKORAL sales grew by 16.4% to €17.4 million, supported by a sale to combat a cholera outbreak [24] - XGIC sales surged to €7.5 million from €1 million in 2024, benefiting from a supply to address a chikungunya outbreak [25] Market Data and Key Metrics Changes - The company secured additional marketing authorizations for XGIC in the UK, Brazil, and label extensions in Europe [6] - The company responded to public health needs by supplying vaccines during outbreaks in La Réunion and Mayotte [5][6] Company Strategy and Development Direction - The company aims to address unmet medical needs and expand its vaccine portfolio, particularly focusing on Lyme disease, chikungunya, and Shigella [5][19] - The partnership with CSL for vaccine distribution in Germany is expected to enhance market access and sales potential [56] - The company is focused on strategic investments in R&D and anticipates continuous growth in product sales [30][32] Management's Comments on Operating Environment and Future Outlook - Management highlighted the importance of the Lyme disease vaccine program as a major catalyst for future growth [32] - The company expects a significantly lower cash burn in operations, targeting a reduction of over 50% year-over-year [30] - Management expressed confidence in the ongoing clinical trials and the potential for successful vaccine approvals [32] Other Important Information - The company reported a gross margin improvement on commercial products, with IXIARO achieving a gross margin of 65.5% [26] - R&D expenses increased to €32.4 million, driven by costs related to the Shigella vaccine candidate [27] Q&A Session Summary Question: Will there be additional revenue recognition for the 40,000 doses sold to the French government in Q3? - Management confirmed that all doses were shipped in the first half of the year, and revenue will be recognized in that period [40] Question: Can you provide insight on the demand scenarios for XGIC considering the chikungunya outbreak? - Management acknowledged the critical epidemiological situation and emphasized the company's readiness to respond to outbreaks [38] Question: What is the expected timeline for the Lyme vaccine data readouts? - Management indicated that top-line data is expected by the end of the first quarter of 2026, with detailed results to follow [47][66] Question: What are the expectations for sales uptake in the traveler market for XGIC? - Management noted that the recent lifting of restrictions should lead to increased market uptake and ongoing discussions for stockpiling in the U.S. [56] Question: What is the bar for success for the Lyme vaccine trial? - Management stated that while direct comparisons to previous vaccines are challenging, they expect a different efficacy profile based on their current study design [62]

Financial Data and Key Metrics Changes - The company is targeting a quarterly EPS run rate of $2, which is considered achievable with concrete plans in place [9][13] - Free cash flow generation is prioritized, with a guide of $700 to $800 million for the year, translating to approximately $7 per share [18][68] - The company reported a sequential negative impact of $25 million in Q3 due to inventory reduction efforts [17][22] Business Line Data and Key Metrics Changes - In the Engineered Materials segment, there has been a noted weakness in demand from China and Europe, while the Americas remained stable [6][7] - The Acetyl segment is expected to see flat performance compared to Q2, with no significant changes anticipated in the near term [98] Market Data and Key Metrics Changes - The company is experiencing the lowest demand levels in the Western Hemisphere for acetyl products in 20 years, with a 5% to 6% decline in volumes compared to the first half of the previous year [72][73] - The visibility of the order book has decreased significantly, with only two weeks of reliable orders in Engineered Materials [58] Company Strategy and Development Direction - The company is focusing on cost structure improvements and executing differentiated business models to achieve its EPS target [9][13] - There is an emphasis on diversifying the Engineered Materials business beyond automotive applications, exploring opportunities in drug delivery, performance footwear, and clean energy [94] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to adapt to changing demand and emphasized the importance of cash generation [18][37] - The company is prepared to pivot with demand changes and is actively working on controllable actions to improve profitability [13][39] Other Important Information - The company is undergoing a divestiture process, with the MicroMax project progressing well and expected to yield positive results in the second half of the year [102] - The company has extended its revolver to 2030, ensuring sufficient liquidity to address upcoming maturities [60][62] Q&A Session Summary Question: What end markets are seeing weakening demand? - Management noted a pullback in China automotive orders and some weakness in European demand, while the Americas remained stable [6][7] Question: How does the company plan to achieve the $2 EPS target? - The company has identified four controllable areas to improve cost structure and pricing, which will help reach the target, albeit potentially delayed [9][13] Question: Are tariffs affecting the tow business in China? - Management confirmed that the tow business in China is not impacted by tariffs as it operates through a joint venture [27] Question: What is the outlook for the acetic acid business in China? - Management indicated that the acetic acid business is currently breakeven and is pivoting towards downstream products for better margins [28] Question: How does the company view the current demand environment? - Management described the demand environment as uncertain, with customers reducing inventories, impacting sales [82][84] Question: What is the status of the MicroMax divestiture process? - The MicroMax process is progressing well, with management confident in achieving positive outcomes in the near future [102]

Financial Data and Key Metrics Changes - For the quarter ended June 30, core net investment income was $0.27 per share, while GAAP net investment income was $0.25 per share [5][17] - As of June 30, net asset value (NAV) was $10.96 per share, down 1% from $11.07 per share in the prior quarter [17] - The debt to equity ratio was 1.3 times, indicating a diversified capital structure across multiple funding sources [17] Business Line Data and Key Metrics Changes - The portfolio grew to $2.4 billion, up from $2.3 billion in the prior quarter, with a weighted average yield on debt investments of 10.4% [12][18] - The portfolio comprised 90% first lien senior secured debt, with only 1% in subordinated debt and 2% in equity of PSSL [18] - The weighted average debt to EBITDA for new platform investments was 3.8 times, with an interest coverage ratio of 2.6 times [8][19] Market Data and Key Metrics Changes - The company noted a rebound in deal activity, which is expected to lead to increased loan originations in the second half of 2025 [4][6] - The pricing on high-quality first lien term loans in the core middle market is over plus $4.75 to $5.25, with meaningful covenant protections [7][10] Company Strategy and Development Direction - The company formed a new joint venture with Hamilton Lane, committing $200 million in capital, with an expected total portfolio of $500 million [6][14] - The focus remains on capital preservation and finding investment opportunities in growing middle market companies with high free cash flow conversion [15] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the strong outlook for the remainder of the year, anticipating continued net investment income growth and full dividend coverage [6][36] - Credit quality remains strong, with a low nonaccrual rate of 1% at cost and 0.5% at market value [8][18] Other Important Information - The company raised $32 million from the issuance of 2.8 million shares at an average price of $11.31 per share during the quarter [13] - The PSSL joint venture portfolio totaled $1.1 billion, with plans to grow to $1.4 billion [14] Q&A Session Summary Question: How much of the $500 million could be deployed over the next few quarters? - Management anticipates a ramp-up period of 12 to 18 months for deploying the capital, with potential for growth beyond the initial amount [23][24] Question: What are the long-term growth plans for PFLT and PNNT? - Management emphasized that growth will be organic based on market opportunities, with the potential for future mergers always on the table [28][30] Question: What is the timing for net investment income to fully cover the dividend? - Management identified three levers for NII growth: increasing leverage to target ratios, filling out the PSSL joint venture, and ramping up the new Hamilton Lane JV [33][35] Question: What is the current state of EBITDA growth at the portfolio company level? - EBITDA growth is generally in the mid to upper single digits, with low nonaccruals and maintained leverage levels [36][38] Question: Will the high level of unrestricted cash be directed towards the JV? - Some of the unrestricted cash will be used for the JV, but it also reflects timing from cash management [41] Question: Is there expected to be improved loan pricing power? - Management hopes to maintain or expand loan spreads due to increased supply, while prioritizing credit quality [42][44] Question: Is there a mix shift in the pipeline regarding industries or borrowers? - Recently, there has been an increase in new platforms coming to the company, with a focus on incumbency and add-on loans [48][51]

Financial Data and Key Metrics Changes - The company's net contribution for Q2 2025 increased by 26% year over year to $210 million, while adjusted EBITDA grew by 31% year over year to $72 million, with an adjusted EBITDA margin of 34%, expanding 140 basis points from the previous year [13][24][23] - Assets Under Administration (AUA) increased by 54% year over year to $7.5 billion, and funded accounts grew by 14% year over year to 3.63 million [24][23] - Adjusted EPS for the quarter was $0.56 compared to $0.51 in Q2 2024 [26] Business Line Data and Key Metrics Changes - Net trading contribution from equities, commodities, and currencies grew by 37% year over year to $114 million, driven by a 54% increase in invested amount per trade [24][25] - Net contribution from crypto increased by 34% year over year to $27 million, primarily due to higher invested amounts per trade, despite lower overall crypto activity [24][25] - Interest earning assets contributed $46 million, up 1% year over year, while eToro Money contribution grew by 17% year over year to $18 million [25] Market Data and Key Metrics Changes - The company expanded its global footprint by activating its license in Singapore, positioning itself to serve Asia's growing investor base [13] - The U.S. market saw significant expansion in crypto offerings, now providing access to over 100 different crypto assets [15][24] Company Strategy and Development Direction - eToro aims to be a leading trading investment platform, focusing on product development across four strategic pillars: trading, investing, wealth management, and neo banking [12] - The company is committed to leveraging AI technology to enhance the investing experience and democratize access to quantitative trading tools [19][20] - eToro is exploring the tokenization of assets, anticipating a significant transfer of wealth as traditional assets move onto the blockchain [15][39] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth opportunities in the U.S. and Asia, particularly with the recent regulatory developments around crypto [15][70] - The company is focused on sustainable, profitable revenue growth through diversification of revenue streams and disciplined cost management [22][23] - Management noted that while Q2 saw elevated trading activity, normalization is expected in subsequent months, with a positive outlook for crypto activity in July [27][34] Other Important Information - The company launched the eToro MoneyCard across Europe, which offers a 4% stockbroker reward on purchases [18] - eToro is actively working on expanding its product offerings, including the introduction of staking and CopyTrader for U.S. customers [48][70] Q&A Session Summary Question: When does eToro plan to provide calls and puts options to European investors? - eToro plans to expand options trading to Europe, UAE, Singapore, and Australia over the next twelve months, following initial launches in the U.S. and the UK [28] Question: Can you provide insights on the cadence throughout the quarter? - Elevated trading activity was observed in April, normalizing towards the end of Q2, with a noted increase in crypto trading in July [31][34] Question: What is the revenue opportunity from tokenized stocks? - eToro anticipates a significant process of digitization and tokenization of assets, expecting $100 trillion of assets to move on-chain over the next twenty years [38][39] Question: What is the update on CopyTrader in the U.S.? - eToro plans to launch CopyTrader for U.S. customers later this year, with significant progress made in expanding crypto offerings [48][70] Question: How is account growth dynamics across regions? - Growth is balanced across regions, with notable growth in the UAE, and overall funded accounts are expected to continue growing [51] Question: What is the outlook for funded account growth in the APAC region? - The company sees significant growth opportunities in Asia, particularly through its new license in Singapore [64] Question: What is the percentage mix from CFDs in net trading income? - The company does not break down net trading income by transaction type but aims to reach a 20% mark for CFDs in the coming months [94]